These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


861 related items for PubMed ID: 17194635

  • 1. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 2. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C, De Rojas MV, Lojo S, Salorio MS.
    Retina; 1998 Sep; 18(6):546-50. PubMed ID: 9869464
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 4. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 May; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 5. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 6. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M, Rollín R, Mediero A, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R.
    Mol Vis; 2005 Jul 07; 11():461-71. PubMed ID: 16030497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy.
    Nawaz MI, Van Raemdonck K, Mohammad G, Kangave D, Van Damme J, Abu El-Asrar AM, Struyf S.
    Exp Eye Res; 2013 Apr 07; 109():67-76. PubMed ID: 23352833
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E, Tekin H, Akar S, Ekmekçi OB, Donma O, Koldaş L, Ozkan S.
    Ophthalmic Res; 2003 Apr 07; 35(5):251-5. PubMed ID: 12920337
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME.
    Invest Ophthalmol Vis Sci; 1994 Mar 07; 35(3):900-6. PubMed ID: 8125753
    [Abstract] [Full Text] [Related]

  • 18. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM, Nawaz MI, Ola MS, De Hertogh G, Opdenakker G, Geboes K.
    Acta Ophthalmol; 2013 May 07; 91(3):e169-77. PubMed ID: 23387388
    [Abstract] [Full Text] [Related]

  • 19. Lipid peroxidation in proliferative vitreoretinopathies.
    Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD.
    Eye (Lond); 1999 Apr 07; 13 ( Pt 2)():183-8. PubMed ID: 10450379
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun 07; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.